CONMED (CNMD)
(Delayed Data from NYSE)
$71.08 USD
-1.68 (-2.31%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $71.12 +0.04 (0.06%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC4/24/24 |
---|---|
Current Quarter | 0.74 |
EPS Last Quarter | 1.06 |
Last EPS Surprise | -4.50% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.34 |
Next Year | 5.67 |
EPS (TTM) | 3.45 |
P/E (F1) | 16.78 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 307.06M | 342.86M | 1.35B | 1.47B |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 308.00M | 350.65M | 1.35B | 1.48B |
Low Estimate | 304.89M | 339.90M | 1.34B | 1.44B |
Year ago Sales | 295.47M | 317.65M | 1.24B | 1.35B |
Year over Year Growth Est. | 3.92% | 7.94% | 8.34% | 8.80% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.74 | 0.99 | 4.34 | 5.67 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.74 | 1.11 | 4.36 | 5.80 |
Low Estimate | 0.73 | 0.94 | 4.30 | 5.51 |
Year ago EPS | 0.66 | 0.83 | 3.45 | 4.34 |
Year over Year Growth Est. | 12.12% | 19.28% | 25.80% | 30.65% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.74 | 0.99 | 4.34 | 5.67 |
7 Days Ago | 0.74 | 0.99 | 4.34 | 5.67 |
30 Days Ago | 0.74 | 0.99 | 4.34 | 5.67 |
60 Days Ago | 0.77 | 1.01 | 4.35 | 5.68 |
90 Days Ago | 0.92 | 1.09 | 4.42 | 5.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.74 | 0.99 | 4.34 | 5.67 |
Zacks Consensus Estimate | 0.74 | 0.99 | 4.34 | 5.67 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.06 | 0.90 | 0.83 | 0.66 | NA |
Estimate | 1.11 | 0.83 | 0.79 | 0.60 | NA |
Difference | -0.05 | 0.07 | 0.04 | 0.06 | 0.03 |
Surprise | -4.50% | 8.43% | 5.06% | 10.00% | 4.75% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more